The State of Texas Attorney General Files Lawsuit Against Acetaminophen Manufacturers Over Autism Claims

The top legal official in Texas Paxton is suing the manufacturers of Tylenol, claiming the corporations concealed potential risks that the medication created to pediatric neurological development.

The lawsuit comes four weeks after President Donald Trump publicized an unverified association between using Tylenol - referred to as acetaminophen - while pregnant and autism in offspring.

Paxton is suing the pharmaceutical giant, which formerly manufactured the drug, the only pain reliever suggested for expectant mothers, and Kenvue, which presently makes it.

In a statement, he claimed they "misled consumers by profiting off of discomfort and promoting medication without regard for the dangers."

The company asserts there is lacking scientific proof linking Tylenol to autism spectrum disorder.

"These corporations deceived for years, knowingly endangering countless individuals to line their pockets," the attorney general, a Republican, stated.

Kenvue stated officially that it was "seriously troubled by the dissemination of inaccurate information on the reliability of acetaminophen and the possible consequences that could have on the well-being of US mothers and children."

On its official site, Kenvue also stated it had "regularly reviewed the relevant science and there is insufficient valid information that indicates a established connection between using acetaminophen and autism spectrum disorder."

Organizations representing medical professionals and health professionals agree.

The leading OB-GYN organization has said paracetamol - the main ingredient in acetaminophen - is one of the few options for pregnant women to address discomfort and fever, which can create serious health risks if left untreated.

"In more than two decades of research on the use of acetaminophen in gestation, not a single reputable study has definitively established that the usage of paracetamol in any period of gestation results in neurodevelopmental disorders in offspring," the group said.

The lawsuit cites current declarations from the previous government in arguing the medication is potentially dangerous.

Last month, the former president caused concern from public health officials when he told pregnant women to "fight like hell" not to take acetaminophen when sick.

The FDA then issued a notice that doctors should contemplate reducing the usage of acetaminophen, while also declaring that "a proven link" between the medication and autism spectrum disorder in young ones has not been proven.

The Health Department head Robert F Kennedy Jr, who supervises the FDA, had pledged in April to undertake "comprehensive study program" that would identify the cause of autism spectrum disorder in a short period.

But specialists cautioned that discovering a single cause of autism spectrum disorder - considered by experts to be the consequence of a intricate combination of genetic and environmental factors - would prove challenging.

Autism is a type of permanent neurological difference and disability that influences how people encounter and engage with the surroundings, and is recognized using physician assessments.

In his lawsuit, the attorney general - a Trump ally who is running for US Senate - asserts Kenvue and J&J "deliberately disregarded and sought to suppress the research" around paracetamol and autism spectrum disorder.

The lawsuit attempts to require the firms "eliminate any promotional materials" that asserts Tylenol is secure for expectant mothers.

This legal action echoes the grievances of a group of guardians of young ones with autism spectrum disorder and ADHD who sued the manufacturers of acetaminophen in 2022.

A federal judge threw out the lawsuit, stating studies from the family's specialists was not conclusive.